As previously reported, Craig-Hallum initiated coverage of Agiliti with a Buy rating and $23 price target. The firm notes that after helping hospitals deal with a massive influx of patients during COVID, which drove adoption and strong financial performance, the past year has been rough. Craig-Hallum believes the corner is being turned and as a result Agiliti can return to high single digit revenue growth.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AGTI:
- Agiliti price target lowered to $7.50 from $13 at Citi
- Agiliti price target lowered to $8 from $10 at Morgan Stanley
- Agiliti upgraded to Buy from Neutral at UBS
- Agiliti rises 14.5%
- Agiliti rises 14.6%
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue